| Host |
Mouse |
| Klon |
144B |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
144B |
0.5 ml |
Concentrate |
CE/IVD |
MOB117-05 |
-
|
| Host |
Mouse |
| Klon |
144B |
| Format |
Ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
144B |
6 ml |
Ready-to-use |
CE/IVD |
PDM094 |
-
|
| Host |
Rabbit |
| Klon |
SP16 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
1 ml |
Concentrate |
CE/IVD |
RMAB012 |
-
|
| Host |
Rabbit |
| Klon |
SP16 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
0.1 ml |
Concentrate |
CE/IVD |
RMAB012-01 |
-
|
| Host |
Rabbit |
| Klon |
SP16 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
0.5 ml |
Concentrate |
CE/IVD |
RMAB012-05 |
-
|
| Host |
Rabbit |
| Klon |
SP16 |
| Format |
Ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
Rabbit IgG |
| Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
6 ml |
Ready-to-use |
CE/IVD |
RMPD012 |
-
|
| Host |
Mouse |
| Klon |
ZM54 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
1.0 ml |
Concentrate |
CE/IVD |
Z2364ML |
-
|
| Host |
Mouse |
| Klon |
ZM54 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node. |
| Verdünnung |
- |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
7 ml |
Ready-to-use |
CE/IVD |
Z2364MP |
-
|
| Host |
Mouse |
| Klon |
ZM54 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
0.5 ml |
Concentrate |
CE/IVD |
Z2364MS |
-
|
| Host |
Mouse |
| Klon |
ZM54 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
0.1 ml |
Concentrate |
CE/IVD |
Z2364MT |
-
|
| Host |
Monospecific Rabbit |
| Klon |
ZR286 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
1 ml |
Concentrate |
CE/IVD |
Z2601RL |
-
|
| Host |
Monospecific Rabbit |
| Klon |
ZR286 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
IgG |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
7 ml |
Ready-to-use |
CE/IVD |
Z2601RP |
-
|
| Host |
Monospecific Rabbit |
| Klon |
ZR286 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
0.5 ml |
Concentrate |
CE/IVD |
Z2601RS |
-
|
| Host |
Monospecific Rabbit |
| Klon |
ZR286 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG |
| Verdünnung |
Human CD8 recombinant protein |
| Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
0.1 ml |
Concentrate |
CE/IVD |
Z2601RT |
-
|
| Host |
Mouse |
| Klon |
LT8 |
| Format |
Purified |
| Methode |
F, IP, FL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Normal human peripheral blood lymphocytes |
CD8 (T-Cell cytotoxic/suppressor)
|
Zytomed Systems GmbH |
LT8 |
200 µg |
Purified |
RUO |
603-0342 |
-
|
| Host |
Mouse |
| Klon |
4B11 |
| Format |
Lyophilised |
| Methode |
F, P, WB |
| Vorbehandlung |
EDTA |
| Positivkontrolle |
Human Tonsil |
| Verdünnung |
1:20 - 1:40 (P) |
| Isotyp |
Mouse IgG2b |
| Verdünnung |
Synthetic peptide derived from CD8 alpha chain sequence |
CD8 (T-Cell cytotoxic/suppressor)
|
Zytomed Systems GmbH |
4B11 |
1 ml |
Lyophilised |
RUO |
603-0346 |
-
|
| Host |
Mouse |
| Klon |
LT8 |
| Format |
Purified |
| Methode |
F, IP, FL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Normal human peripheral blood lymphocytes |
CD8 (T-Cell cytotoxic/suppressor)
|
Zytomed Systems GmbH |
LT8 |
100 µg |
Purified |
RUO |
603-1226 |
-
|
| Host |
Rat |
| Klon |
YTS105.18 |
| Format |
Purified |
| Methode |
F, FL |
| Isotyp |
Rat IgG2a |
| Verdünnung |
Mouse spleen cells |
CD8 (T-Cell cytotoxic/suppressor) (Low Endotoxin)
|
Zytomed Systems GmbH |
YTS105.18 |
500 µg |
Purified |
RUO |
603-2334 |
-
|
| Host |
Mouse |
| Klon |
MM2/57 |
| Format |
Purified |
| Methode |
F, WB, FL |
| Isotyp |
Mouse IgG2b |
| Verdünnung |
Human platelet membrane |
CD9 (Motility-Related Protein-1)
|
Zytomed Systems GmbH |
MM2/57 |
100 µg |
Purified |
RUO |
603-0412 |
-
|
| Host |
Rabbit |
| Klon |
SP67 |
| Format |
Concentrate |
| Reaktivität |
BV, CK, MS, RT |
| Methode |
P, WB |
| Vorbehandlung |
EDTA |
| Verdünnung |
1:100 |
| Verdünnung |
Synthetic peptide corresponding to human CD10 |
CD10 (CALLA)
|
Zytomed Systems GmbH |
SP67 |
0.1 ml |
Concentrate |
RUO |
503-3670 |
-
|
| Host |
Rabbit |
| Klon |
SP67 |
| Format |
Concentrate |
| Reaktivität |
BV, CK, MS, RT |
| Methode |
P, WB |
| Vorbehandlung |
EDTA |
| Verdünnung |
1:100 |
| Verdünnung |
Synthetic peptide corresponding to human CD10 |
CD10 (CALLA)
|
Zytomed Systems GmbH |
SP67 |
0.5 ml |
Concentrate |
RUO |
503-3672 |
-
|
| Host |
Rabbit |
| Klon |
SP67 |
| Format |
Concentrate |
| Reaktivität |
BV, CK, MS, RT |
| Methode |
P, WB |
| Vorbehandlung |
EDTA |
| Verdünnung |
1:100 |
| Verdünnung |
Synthetic peptide corresponding to human CD10 |
CD10 (CALLA)
|
Zytomed Systems GmbH |
SP67 |
1 ml |
Concentrate |
RUO |
503-3674 |
-
|
| Host |
Mouse |
| Klon |
UMAB236 |
| Format |
RTU |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Normal kidney and tonsil |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Human recombinant protein of CD10 |
| Lokalisation |
Cytoplasm (kidney) and cell membrane (tonsil) |
CD10 (CALLA)
|
Biocare Medical |
UMAB236 |
6 ml |
RTU |
CE/IVD |
API3212AA |
-
|
| Host |
Mouse |
| Klon |
56C6 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:20 - 1:30 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
1 ml |
Concentrate |
CE/IVD |
MOB240 |
-
|
| Host |
Mouse |
| Klon |
56C6 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:20 - 1:30 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
0.1 ml |
Concentrate |
CE/IVD |
MOB240-01 |
-
|
| Host |
Mouse |
| Klon |
56C6 |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:20 - 1:30 |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
0.5 ml |
Concentrate |
CE/IVD |
MOB240-05 |
-
|
| Host |
Mouse |
| Klon |
56C6 |
| Format |
Ready-to-use |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
- |
| Isotyp |
Mouse IgG1 |
| Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
6 ml |
Ready-to-use |
CE/IVD |
PDM107 |
-
|
| Host |
Rabbit |
| Klon |
EP195 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
| Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
1 ml |
Concentrate |
CE/IVD |
RMAB037 |
-
|
| Host |
Rabbit |
| Klon |
EP195 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
| Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
0.1 ml |
Concentrate |
CE/IVD |
RMAB037-01 |
-
|
| Host |
Rabbit |
| Klon |
EP195 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Rabbit IgG |
| Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
| Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
0.5 ml |
Concentrate |
CE/IVD |
RMAB037-05 |
-
|
| Host |
Rabbit |
| Klon |
EP195 |
| Format |
Ready-to-use |
| Methode |
P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
| Verdünnung |
- |
| Isotyp |
Rabbit IgG |
| Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
| Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
6 ml |
Ready-to-use |
CE/IVD |
RMPD037 |
-
|
| Host |
Mouse |
| Klon |
OX-42 |
| Format |
Purified |
| Methode |
F, IP, FL |
| Isotyp |
Mouse IgG2a |
| Verdünnung |
Rat peritoneal macrophages |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
OX-42 |
100 µg |
Purified |
RUO |
603-0455 |
-
|
| Host |
Mouse |
| Klon |
ICRF44 |
| Format |
Purified |
| Methode |
F, IP, FL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Rheumatoid synovial cells and human monocytes |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
ICRF44 |
200 µg |
Purified |
RUO |
603-0457 |
-
|
| Host |
Mouse |
| Klon |
ICRF44 |
| Format |
Purified |
| Methode |
F, IP, FL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Rheumatoid synovial cells and human monocytes |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
ICRF44 |
100 µg |
Purified |
RUO |
603-0458 |
-
|
| Host |
Mouse |
| Klon |
ICRF44 |
| Format |
Purified |
| Methode |
F, FL |
| Isotyp |
Mouse IgG1 |
| Verdünnung |
Rheumatoid synovial cells and human monocytes |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
ICRF44 |
20 µg |
Purified |
RUO |
603-0459 |
-
|
| Host |
Rat |
| Klon |
M1/70.15 |
| Format |
Purified |
| Methode |
F, P, IP, FL |
| Isotyp |
Rat IgG2b |
| Verdünnung |
T cell enriched splenocytes from B10 mice |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
M1/70.15 |
250 µg |
Purified |
RUO |
603-0461 |
-
|
| Host |
Rat |
| Klon |
M1/70.15 |
| Format |
Purified |
| Methode |
F, P, IP, FL |
| Isotyp |
Rat IgG2b |
| Verdünnung |
T cell enriched splenocytes from B10 mice |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
M1/70.15 |
100 µg |
Purified |
RUO |
603-0462 |
-
|
| Host |
Mouse |
| Klon |
5D11 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Diva modified Citrate pH 6.2 |
| Positivkontrolle |
Skin |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cell membrane |
CD11c
|
Biocare Medical |
5D11 |
0.1 ml |
Concentrate |
CE/IVD |
ACI3122A |
-
|
| Host |
Mouse |
| Klon |
5D11 |
| Format |
Concentrate |
| Methode |
P |
| Vorbehandlung |
Diva modified Citrate pH 6.2 |
| Positivkontrolle |
Skin |
| Verdünnung |
1:50 - 1:100 |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cell membrane |
CD11c
|
Biocare Medical |
5D11 |
0.5 ml |
Concentrate |
CE/IVD |
ACI3122B |
-
|
| Host |
Mouse |
| Klon |
5D11 |
| Format |
Ready-to-use |
| Methode |
P |
| Vorbehandlung |
Diva modified Citrate pH 6.2 |
| Positivkontrolle |
Skin |
| Verdünnung |
- |
| Isotyp |
Mouse IgG2a |
| Lokalisation |
Cell membrane |
CD11c
|
Biocare Medical |
5D11 |
6 ml |
Ready-to-use |
CE/IVD |
API3122AA |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM103 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant human ITGAX protein fragment (aa 637-827) |
| Lokalisation |
Cell membrane |
CD11c
|
Zeta Corporation |
ZM103 |
1 ml |
Concentrate |
CE/IVD |
Z2414ML |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM103 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, lymph node. |
| Verdünnung |
- |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant human ITGAX protein fragment (aa 637-827) |
| Lokalisation |
Cell membrane |
CD11c
|
Zeta Corporation |
ZM103 |
7 ml |
Ready-to-use |
CE/IVD |
Z2414MP |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM103 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant human ITGAX protein fragment (aa 637-827) |
| Lokalisation |
Cell membrane |
CD11c
|
Zeta Corporation |
ZM103 |
0.5 ml |
Concentrate |
CE/IVD |
Z2414MS |
-
|
| Host |
Monospecific Mouse |
| Klon |
ZM103 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Vorbehandlung |
Citrate or EDTA |
| Positivkontrolle |
Tonsil, lymph node. |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /κ |
| Verdünnung |
Recombinant human ITGAX protein fragment (aa 637-827) |
| Lokalisation |
Cell membrane |
CD11c
|
Zeta Corporation |
ZM103 |
0.1 ml |
Concentrate |
CE/IVD |
Z2414MT |
-
|
| Host |
Mouse |
| Klon |
ZM287 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Bone marrow |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /k |
| Verdünnung |
Recombinant fragment (around a50-250) of human ANPEP protein |
| Lokalisation |
Cytoplasm |
CD13
|
Zeta Corporation |
ZM287 |
1 ml |
Concentrate |
CE/IVD |
Z2524ML |
-
|
| Host |
Mouse |
| Klon |
ZM287 |
| Format |
Ready-to-use |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Bone marrow |
| Verdünnung |
- |
| Isotyp |
IgG1 /k |
| Verdünnung |
Recombinant fragment (around a50-250) of human ANPEP protein |
| Lokalisation |
Cytoplasm |
CD13
|
Zeta Corporation |
ZM287 |
7 ml |
Ready-to-use |
CE/IVD |
Z2524MP |
-
|
| Host |
Mouse |
| Klon |
ZM287 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Bone marrow |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /k |
| Verdünnung |
Recombinant fragment (around a50-250) of human ANPEP protein |
| Lokalisation |
Cytoplasm |
CD13
|
Zeta Corporation |
ZM287 |
0.5 ml |
Concentrate |
CE/IVD |
Z2524MS |
-
|
| Host |
Mouse |
| Klon |
ZM287 |
| Format |
Concentrate |
| Reaktivität |
- |
| Methode |
P |
| Positivkontrolle |
Bone marrow |
| Verdünnung |
1:100 - 1:200 |
| Isotyp |
IgG1 /k |
| Verdünnung |
Recombinant fragment (around a50-250) of human ANPEP protein |
| Lokalisation |
Cytoplasm |
CD13
|
Zeta Corporation |
ZM287 |
0.1 ml |
Concentrate |
CE/IVD |
Z2524MT |
-
|
| Host |
Mouse |
| Klon |
MMA |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgM kappa |
| Lokalisation |
Cell Membrane |
CD15
|
Diagnostic Biosystems |
MMA |
1 ml |
Concentrate |
CE/IVD |
MOB365 |
-
|
| Host |
Mouse |
| Klon |
MMA |
| Format |
Concentrate |
| Methode |
F, P |
| Vorbehandlung |
Citrate |
| Positivkontrolle |
Tonsil |
| Verdünnung |
1:25 - 1:50 |
| Isotyp |
Mouse IgM kappa |
| Lokalisation |
Cell Membrane |
CD15
|
Diagnostic Biosystems |
MMA |
0.1 ml |
Concentrate |
CE/IVD |
MOB365-01 |
-
|